ResMed Inc. CEO Executes Strategic Stock Transactions

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) has released an update.

ResMed Inc.’s CEO, Michael J. Farrell, has executed a series of stock transactions as part of a pre-planned trading arrangement. The transactions involved the acquisition and disposal of ResMed common stock, with significant movements including the sale of shares at a weighted average price of $246.259. These strategic moves reflect the executive’s engagement in managing his stock portfolio within the framework of regulatory guidelines.

For further insights into AU:RMD stock, check out TipRanks’ Stock Analysis page.

Trending Articles

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.